Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Treasury Stock
Beginning Balance (in shares) at Dec. 31, 2018   95,991,000       2,341,000
Beginning Balance at Dec. 31, 2018 $ 1,063,024 $ 96 $ 1,187,683 $ (492) $ (58,793) $ (65,470)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)   7,000       89,000
Stock option exercises 1,877   (837)     $ 2,714
Issuance of restricted stock (in shares)           1,130,000
Issuance of restricted stock 0   (34,456)     $ 34,456
Treasury stock purchase, at cost (in shares)           143,000
Treasury stock purchased, at cost (5,016)   437     $ (5,453)
Stock-based compensation 15,123   15,123      
Other comprehensive loss - derivative instruments (806)     (806)    
Foreign currency translation (99)     (99)    
Net income 11,272       11,272  
Ending Balance (in shares) at Mar. 31, 2019   95,998,000       1,265,000
Ending Balance at Mar. 31, 2019 1,085,375 $ 96 1,167,950 (1,372) (47,546) $ (33,753)
Beginning Balance (in shares) at Dec. 31, 2019   96,100,000       1,356,000
Beginning Balance at Dec. 31, 2019 1,172,926 $ 96 1,222,356 (2,348) (7,695) $ (39,483)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)   188,000       151,000
Stock option exercises 4,906   350     $ 4,556
Issuance of restricted stock (in shares)           1,345,000
Issuance of restricted stock 0   (40,449)     $ 40,449
Treasury stock purchase, at cost (in shares)           151,000
Treasury stock purchased, at cost (3,493)   2,133     $ (5,626)
Stock-based compensation 14,819   14,819      
Other comprehensive loss - derivative instruments (3,415)     (3,415)    
Foreign currency translation (505)     (505)    
Net income 5,605       5,605  
Ending Balance (in shares) at Mar. 31, 2020   96,288,000       11,000
Ending Balance at Mar. 31, 2020 $ 1,190,843 $ 96 $ 1,199,209 $ (6,268) $ (2,090) $ (104)